PBS updates

Vyxeos (Daunorubicin + cytarabine)

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial · INJECTION · PBS code 14661P

AUTHORITY_REQUIRED

What it costs

AU$8215 PBS-determined price per pack

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2024-12-01.
  • • Repeats: 3.
  • • PBS program: IP.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Acute Myeloid Leukaemia


Consolidation therapy


The treatment must be for consolidation treatment following induction treatment with this product; AND

The condition must be either: (i) newly diagnosed therapy-related acute myeloid leukaemia (AML), (ii) newly diagnosed AML with myelodysplasia-related changes (MRC) (prior myelodysplastic syndromes (MDS) or MDS-related cytogenetic or molecular abnormality); AND

The treatment must not exceed two cycles of consolidation therapy under this restriction.

This drug is not PBS-subsidised if it is administered to an in-patient in a public hospital setting.

The prescribed dose must be according to the Therapeutic Goods Administration (TGA) Product Information.

Each prescription must include the amount of daunorubicin with cytarabine (Vyxeos) that is appropriate to be prescribed for the patient. For the purposes of the authority application, the maximum amount requested is based on the daunorubicin dose only. The prescribed amount of daunorubicin must be expressed in milligrams.

Sponsor: JAZZ PHARMACEUTICALS ANZ PTY LTD ABN 83 643 560 534

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.